Evidence map›Paper›PMID 36156831›Full record

ArticleProtein science : a publication of the Protein Society2022

Hybrid in vitro/in silico analysis of low-affinity protein-protein interactions that regulate signal transduction by Sema6D.

Tsubasa Tanaka, Toru Ekimoto, Meri Nagatomo, Makiko Neyazaki, Erena Shimoji, Tsutomu Yamane, Sakura Kanagawa, Rika Oi, Emiko Mihara, Junichi Takagi and 3 more

Open access · greenAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Tsubasa TanakaGraduate School of Medical Life Science, Yokohama City University, Yokohama, Kanagawa, Japan.ORCID 0000-0003-3189-0352
Toru EkimotoGraduate School of Medical Life Science, Yokohama City University, Yokohama, Kanagawa, Japan.ORCID 0000-0001-7186-0292
Meri NagatomoGraduate School of Medical Life Science, Yokohama City University, Yokohama, Kanagawa, Japan.
Makiko NeyazakiGraduate School of Medical Life Science, Yokohama City University, Yokohama, Kanagawa, Japan.
Erena ShimojiGraduate School of Medical Life Science, Yokohama City University, Yokohama, Kanagawa, Japan.
Tsutomu YamaneCenter for Computational Science, RIKEN, Yokohama, Kanagawa, Japan.
Sakura KanagawaGraduate School of Medical Life Science, Yokohama City University, Yokohama, Kanagawa, Japan.
Rika OiGraduate School of Medical Life Science, Yokohama City University, Yokohama, Kanagawa, Japan.
Emiko MiharaInstitute for Protein Research, Osaka University, Suita, Osaka, Japan.
Junichi TakagiInstitute for Protein Research, Osaka University, Suita, Osaka, Japan.ORCID 0000-0002-1219-475X
Satoko AkashiGraduate School of Medical Life Science, Yokohama City University, Yokohama, Kanagawa, Japan.ORCID 0000-0002-8978-6358
Mitsunori IkeguchiGraduate School of Medical Life Science, Yokohama City University, Yokohama, Kanagawa, Japan.ORCID 0000-0003-3199-6931
Terukazu NogiGraduate School of Medical Life Science, Yokohama City University, Yokohama, Kanagawa, Japan.ORCID 0000-0001-8663-3519
Yokohama City University · JPProtein Research Foundation · JPRIKEN Center for Computational Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Semaphorins constitute a large family of secreted and membrane-bound proteins that signal through cell-surface receptors, plexins. Semaphorins generally use low-affinity protein-protein interactions to bind with their specific plexin(s) and regulate distinct cellular processes such as neurogenesis, immune response, and organogenesis. Sema6D is a membrane-bound semaphorin that interacts with class A plexins. Sema6D exhibited differential binding affinities to class A plexins in prior cell-based assays, but the molecular mechanism underlying this selectivity is not well understood. Therefore, we performed hybrid in vitro/in silico analysis to examine the binding mode of Sema6D to class A plexins and to identify residues that give rise to the differential affinities and thus contribute to the selectivity within the same class of semaphorins. Our biophysical binding analysis indeed confirmed that Sema6D has a higher affinity for Plexin-A1 than for other class A plexins, consistent with the binding selectivity observed in the previous cell-based assays. Unexpectedly, our present crystallographic analysis of the Sema6D-Plexin-A1 complex showed that the pattern of polar interactions is not interaction-specific because it matches the pattern in the prior structure of the Sema6A-Plexin-A2 complex. Thus, we performed in silico alanine scanning analysis and discovered hotspot residues that selectively stabilized the Sema6D-Plexin-A1 pair via Van der Waals interactions. We then validated the contribution of these hotspot residues to the variation in binding affinity with biophysical binding analysis and molecular dynamics simulations on the mutants. Ultimately, our present results suggest that shape complementarity in the binding interfaces is a determinant for binding selectivity.

Indexed as

SemaphorinsCell CommunicationReceptors, Cell SurfaceSignal TransductionReceptors, Cell SurfaceSemaphorinsbinding selectivitycell-surface receptorhybrid in silico/in vitro analysismolecular dynamics simulationprotein-protein interactionsx-ray crystallography

Identifiers

PMID36156831
PMCPMC9601788
OpenAlexW4297256129

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.